| Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. | |
| | |
MedLine Citation:
|
PMID: 16700077 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: This study proposes to complete declarative studies by describing the prescriptions of anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. METHODS: This cross-sectional study analyzes all the hypnotic, anxiolytic, and antidepressant prescriptions (ATC codes beginning with N05B, N05C, and N06A, respectively) sent by adolescents (aged 13-17 years) to the French Health Insurance system of the study region for reimbursement during one year (2002). It was performed in a southern France area with 120,908 adolescents covered by this insurance scheme. Adverse drug reactions (ADRs) recorded in the Pharmacovigilance database were also studied. RESULTS: Three thousand two hundred and eighty-six adolescents (2.7% of adolescent population) had at least one prescription of the studied drugs. This prevalence increased with age and female sex, leading to a maximum of 6.3% for the 17-year-old girls. Two thousand four hundred and thirty-one of adolescents were dispensed anxiolytics, 935 antidepressants, and 548 hypnotics. The most dispensed drugs were zolpidem, zopiclone, and niaprazine for hypnotics; hydroxyzine, etifoxine, and bromazepam for anxiolytics; and paroxetine, sertraline, and fluoxetine for antidepressants. Zolpidem, hydroxyzine, and paroxetine accounted, respectively, for 82.9%, 57.1%, and 59.8% of the prescriptions. 75.5% of hypnotics users had only one prescription, 77.4% for anxiolytics, and 57.4% for antidepressants. Three ADRs were reported. CONCLUSIONS: This study confirms the large use of psychotropics in French adolescents and the influence of age and sex. Also, the results underline treatment for most adolescents is short, which may be beneficial for hypnotics and anxiolytics but not for antidepressants. |
| | |
Authors:
|
Julien Mancini; Xavier Thirion; Alain Masut; Carine Saillard; Vincent Pradel; Fanny Romain; Marie-Joseph Jean Pastor; Christine Coudert; Joëlle Micallef |
Related Documents
:
|
21395987 - Brief report on the status of kozlov's pika, ochotona koslowi (büchner), in the east k... 18519017 - Review of adolescent urinary tract infection. 10368207 - A morphometric and ultrastructural study of the changes in the lamina propria in adoles... 11796147 - Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine adminis... 22343057 - Protective factors and suicidality in members of arab kindred. 20836597 - Parenting knowledge: experiential and sociodemographic factors in european american mot... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Pharmacoepidemiology and drug safety Volume: 15 ISSN: 1053-8569 ISO Abbreviation: Pharmacoepidemiol Drug Saf Publication Date: 2006 Jul |
Date Detail:
|
Created Date: 2006-08-14 Completed Date: 2006-11-27 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 9208369 Medline TA: Pharmacoepidemiol Drug Saf Country: England |
Other Details:
|
Languages: eng Pagination: 494-503 Citation Subset: IM |
Copyright Information:
|
Copyright (c) 2006 John Wiley & Sons, Ltd. |
Affiliation:
|
Centre for Evaluation and Information on Pharmacodependence (CEIP), Public Health Department, School of Medicine, Marseille, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adverse Drug Reaction Reporting Systems Anti-Anxiety Agents / adverse effects, therapeutic use* Antidepressive Agents / adverse effects, therapeutic use* Cross-Sectional Studies Drug Prescriptions Drug Utilization Female France Humans Hypnotics and Sedatives / adverse effects, therapeutic use* Male Seasons Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Anxiety Agents; 0/Antidepressive Agents; 0/Hypnotics and Sedatives |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Steroid hormones acutely regulate expression of a Nudix protein-encoding gene in the endometrial epi...
Next Document: Quality of manufacturer provided information on safety and efficacy claims for dietary supplements f...